| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monopar Therapeutics | Chief Operating Officer | Common Stock | 48.3K | $3.94M | $81.67 | Sep 30, 2025 | Direct |
| Monopar Therapeutics | Chief Operating Officer | Restricted Stock Units | 52.6K | $1.14M | $22.00 | Dec 2, 2025 | Direct |
| Monopar Therapeutics | Chief Operating Officer | Stock Options | 8.97K | Dec 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | Dec 2, 2025 | 2 | $0 | 4 | Dec 8, 2025 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Sep 30, 2025 | 3 | -$155K | 4 | Oct 2, 2025 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Jun 30, 2025 | 3 | -$107K | 4 | Jul 2, 2025 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Mar 31, 2025 | 3 | -$27.1K | 4 | Apr 2, 2025 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Mar 4, 2025 | 2 | $0 | 4 | Mar 7, 2025 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Dec 31, 2024 | 3 | -$15.9K | 4 | Jan 2, 2025 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Sep 30, 2024 | 3 | -$3.61K | 4 | Oct 2, 2024 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Jun 30, 2024 | 3 | -$1.48K | 4 | Jul 2, 2024 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Jun 18, 2024 | 2 | $25.6K | 4 | Jun 21, 2024 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Jun 13, 2024 | 3 | $32.9K | 4 | Jun 17, 2024 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Jun 3, 2024 | 2 | $18.5K | 4 | Jun 5, 2024 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | May 29, 2024 | 3 | $23.1K | 4 | May 31, 2024 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | May 22, 2024 | 1 | $0 | 4 | May 24, 2024 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Mar 31, 2024 | 3 | -$2.11K | 4 | Apr 2, 2024 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Dec 31, 2023 | 3 | -$1.05K | 4 | Jan 3, 2024 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Sep 30, 2023 | 3 | -$1.63K | 4 | Oct 3, 2023 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Jun 30, 2023 | 3 | -$3.47K | 4 | Jul 3, 2023 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Mar 31, 2023 | 3 | -$1.6K | 4 | Apr 4, 2023 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Feb 1, 2023 | 2 | $0 | 4 | Feb 3, 2023 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Dec 31, 2022 | 3 | -$3.33K | 4 | Jan 3, 2023 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Nov 14, 2022 | 2 | $49.7K | 4 | Nov 16, 2022 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Sep 30, 2022 | 3 | -$1.81K | 4 | Oct 3, 2022 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Jun 30, 2022 | 3 | -$6.46K | 4 | Jul 1, 2022 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Feb 2, 2022 | 2 | $0 | 4 | Feb 4, 2022 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Jun 1, 2021 | 1 | $0 | 4 | Jun 2, 2021 | Chief Operating Officer |
| MNPR | Monopar Therapeutics | Jun 1, 2021 | 0 | $0 | 3/A | Jun 2, 2021 | Chief Operating Officer |